Skip to content
10-Q

Quarterly Report

Yubo International Biotech Ltd YBGJ

0001640334-24-000849

← back to feed
Filed
May 20, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2024 · May 17, 2024 119.82M sh
Cash And Equivalents Q1 2024 · Mar 31, 2024 $57.02K
Stockholders Equity Q1 2024 · Mar 31, 2024 −$2.07M
Stockholders Equity Q1 2024 · Dec 31, 2023 −$1.84M
Current Liabilities Q1 2024 · Mar 31, 2024 $3.52M
Current Liabilities Q1 2024 · Dec 31, 2023 $3.4M
Total Liabilities Q1 2024 · Mar 31, 2024 $3.61M
Total Liabilities Q1 2024 · Dec 31, 2023 $3.51M
Current Assets Q1 2024 · Mar 31, 2024 $734.86K
Current Assets Q1 2024 · Dec 31, 2023 $725.24K
Total Assets Q1 2024 · Mar 31, 2024 $1.55M
Total Assets Q1 2024 · Dec 31, 2023 $1.67M
Capex Q1 2024 · Mar 31, 2023 $0
Operating Cash Flow Q1 2024 · Mar 31, 2023 −$32.67K
Net Income Q1 2024 · Mar 31, 2023 −$316.67K
Operating Income Q1 2024 · Mar 31, 2023 −$316.53K
Gross Profit Q1 2024 · Mar 31, 2023 $57.69K
Cost Of Revenue Q1 2024 · Mar 31, 2023 $98.93K
Revenue Q1 2024 · Mar 31, 2023 $156.62K